MacroGenics
MGNX
#9311
Rank
A$0.14 B
Marketcap
A$2.27
Share price
-4.46%
Change (1 day)
-56.18%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): A-$0.20

According to MacroGenics's latest financial reports the company's current EPS (TTM) is A-$0.07556. In 2024 the company made an earnings per share (EPS) of A-$1.62 a decrease over its 2023 EPS that were of A-$0.23.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.20-87.75%
2024A-$1.62613.33%
2023A-$0.23-92.31%
2022A-$2.95-42.14%
2021A-$5.0936.44%
2020A-$3.73-21.84%
2019A-$4.78-24.58%
2018A-$6.33675.93%
2017A-$0.82-68.05%
2016A-$2.55168.25%
2015A-$0.95-55%
2014A-$2.123400%
2013A-$0.06044-108.68%
2012A$0.7024.49%
2011A$0.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Xencor
XNCR
A-$2.67 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$2.60-3,540.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.47-15,287.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$9.85-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$19.69-26,160.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$31.01-41,136.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.49-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA